MALKIEL BURTON G received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/4/2023ACC: 0001415889-23-007378
Director
Since Apr 2019
+31.18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
31.18K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+9.13K
Price / share
—
Trade value
—
% of position
10.0%
5/2/2023
91.46K→100.59K
Total
Net shares
+9.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/2/2023 | A · Award | +9.13K | — | — | 10.0% | 91.46K | 100.59K |
| Total | +9.13K | $0.00 | ||||||
Derivative Transactions1
Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
22.04K shares
Shares
+22.04K
Strike price
10.95
Held after
22.04K
Exercisable
—
5/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares22.04K shares | 5/2/2023 | A · Award | +22.04K | 10.95 | — | 22.04K |
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned15K
Total
15K indirect15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 15K | Indirect |
| Total | 15K | 15K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported